SKYE Skye Bioscience: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Logo korporat perusahaan Skye Bioscience Inc. (SKYE)

Skye Bioscience, Inc. (SKYE) relies on the full outsourcing of testing and molecule synthesis through external contractors. The projected n+1 earnings per share trend visualizes these dependencies, where -13.90 expresses the latest metric level. However, sanctions and logistical disruptions are hindering the development of glaucoma therapy, although the implementation of robotic manipulators in laboratories is gradually accelerating the preclinical screening of cannabinoid drugs.

SKYE - Prakiraan wutah bathi resik saben saham ing taun ngarep skyebioscience.com ing rentang 12.04.2024 - 16.11.2026

Skye Bioscience - rincian analitis lan metrik utama (SKYE)

- data kapitalisasi saham perusahaan:
Ringkesan analisis perusahaan:skyebioscience.com, SKYE
Produk merek skyebioscience.com

Long-term asset screening requires an analysis of future cash flows to minimize capital risks. This indicator measures the expected percentage change in earnings per share by comparing current performance with analyst consensus forecasts. For Skye Bioscience, Inc. (SKYE), this calculation is complicated by pre-commercial losses and a reliance on secondary offerings. Assess the probability of cash shortages and competition in the obesity drug segment by examining the company's EPS projections for the coming year.

Analisis pesaing

INDV (indivior.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep collegiumpharma.com (COLL)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cronos Group (CRON)|Canopy Growth Corp - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep HITI (High Tide Inc)|Aurora Cannabis (ACB) - Prakiraan wutah bathi resik saben saham ing taun ngarep|achievelifesciences.com - Prakiraan wutah bathi kanggo taun ngarep|ANEB: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Canndoc (INCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NTRB - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep NSRX|Prakiraan wutah bathi kanggo taun ngarep igcinc.us|Prakiraan wutah bathi kanggo taun ngarep MIRA|floragrowth.ca (FLGC) - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IMCC (IM Cannabis Corp)|Dinamika bathi saben saham sing diarepake ing taun ngarep ADIL|Artelo Biosciences Inc. - Prakiraan wutah bathi kanggo taun ngarep|ENSC: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Titan Pharma (TTNP) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Greenlane Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|INM (inmedpharma.com) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AKAN (Akanda Corp.)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Enveric Corp (ENVB)|Bright Green Corporation - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Hempacco Co., Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep